首页> 美国卫生研究院文献>ChemistryOpen >Rigid Scaffolds: Synthesis of 26‐Bridged Piperazines with Functional Groups in all three Bridges
【2h】

Rigid Scaffolds: Synthesis of 26‐Bridged Piperazines with Functional Groups in all three Bridges

机译:刚性支架:在所有三个桥梁中合成26桥哌嗪其官能团

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The activity of pharmacologically active compounds can be increased by presenting a drug in a defined conformation, which fits exactly into the binding pocket of its target. Herein, the piperazine scaffold was conformationally restricted by substituted C ‐ or C ‐bridges across the 2‐ and 6‐position. At first, a three‐step, one‐pot procedure was developed to obtain reproducibly piperazine‐2,6‐diones with various substituents at the N‐atoms in high yields. Three strategies for bridging of piperazine‐2,6‐diones were pursued: 1. The bicyclic mixed ketals 8‐benzyl‐6‐ethoxy‐3‐(4‐methoxybenzyl)‐6‐(trimethylsilyloxy)‐3,8‐diazabicyclo[3.2.1]octane‐2,4‐diones were prepared by Dieckmann analogous cyclization of 2‐(3,5‐dioxopiperazin‐2‐yl)acetates. 2. Stepwise allylation, hydroboration and oxidation of piperazine‐2,6‐diones led to 3‐(3,5‐dioxopiperazin‐2‐yl)propionaldehydes. Whereas reaction of such an aldehyde with base provided the bicyclic alcohol 9‐benzyl‐6‐hydroxy‐3‐(4‐methoxybenzyl)‐3,9‐diazabicyclo[3.3.1]nonane‐2,4‐dione in only 10 % yield, the corresponding sulfinylimines reacted with base to give ‐(2,4‐dioxo‐3,9‐diazabicyclo[3.3.1]nonan‐6‐yl)‐2‐methylpropane‐2‐sulfinamides in >66 % yield. 3. Transformation of a piperazine‐2,6‐dione with 1,4‐dibromobut‐2‐ene and 3‐halo‐2‐halomethylprop‐1‐enes provided 3,8‐diazabicyclo[3.2.1]octane‐2,4‐dione and 3,9‐diazabicyclo[3.3.1]nonane‐2,4‐dione with a vinyl group at the C ‐ or a methylene group at the C ‐bridge, respectively. Since bridging via sulfinylimines and the one‐pot bridging with 3‐bromo‐2‐bromomethylprop‐1‐ene gave promising yields, these strategies will be exploited for the synthesis of novel receptor ligands bearing various substituents in a defined orientation at the carbon bridge
机译:通过在规定的构象中呈现药物,可以提高药理学活性化合物的活性,这适合其靶标的结合袋。在此,哌嗪支架在横跨2-和6位的取代的C - 或C杂种括起来限制。首先,开发了三步,单罐程序,以获得高产率在N-原子的各种取代基的可重复乳嗪-2,6-二酮。追求哌嗪-2,6-致哌嗪的三种策略:1。双环混合缩酮8-苄基-6-乙氧基-3-(4-甲氧基苄基)-6-(三甲基甲硅烷基甲硅氧基)-3,8-二氮杂双环[3.2 .1]辛烷-2,4-致乙烷由DieckmanN类似的2-(3,5-二恶己酰-2-基)乙酸盐制备。 2.哌嗪-2,6-致哌嗪-2,6-脱酮的逐步烯丙基化,氢化和氧化导致3-(3,5-二恶藻嗪-2-基)的丙醛。而这种醛与碱的反应提供了双环醇9-苄基-6-羟基-3-(4-甲氧基苄基)-3,9-二氮杂基[3.3.1]壬烷-2,4-二酮,仅为10% ,相应的亚磺基亚胺与碱反应,得到 - (2,4-二氧氧-3,9-二氮杂双环[3.3.1]壬烷-2-二酰基)-2-甲基丙烷-2-磺胺酰胺,产率为66%。 3.用1,4-二溴-2-ENE和3-卤素-2-卤甲甲基丙烯-1-辛的哌嗪-2,6-二酮的转化为3,8-二氮杂双环[3.2.1]辛烷-2,4 - 在C - C粒子的C - 或C亚甲基中的乙烯基和3,9-二氮杂双环[3.3.1]壬烷-2,4-二酮。由于通过亚磺基菊和3-溴-2-溴甲基丙烯-1-eNE的一锅桥接产生了有望的产率,因此将利用这些策略在碳桥上的定义取向中携带各种取代基的新型受体配体的合成

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号